Endocrinology

A sleep apnea device may effectively slow the progression of diabetes in at risk patients.

A new trial of vitamin D replacement regimens in young people with cystic fibrosis and exocrine pancreatic insufficiency finds twice-weekly doses of vitamin D2 50,000 IU to be as effective as weekly doses of vitamin D3 50,000 IU.

With funding meant to bolster basic research and help make advances for a variety of conditions the fate of the 21st Century Cure Act is anything but secure even after passage by the US House of Representatives.

Study shows intramuscular injected bone marrow-derived mesenchymal stem cells may be able to restore the myelin sheath and nerve cells in diabetic sciatic nerves.

It may be cool to sip on a Coca-Cola that features your name right on the product, but a report that's been making the rounds details the metabolic roller coaster ride that drinking even a single can unleashes on the body.

At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.

Researchers have long known that single men tend to have more testosterone than comparable men in long-term relationships, but what about men in new relationships? A new study finds that testosterone generally remains at "single-man" levels until couples have been dating for more than a year.

Studies have shown that major depressive disorder (MDD) has a strong link to genetic factors, and many clinicians and researchers believe the same to be true for obesity.

A new investigation of the molecular and cellular mechanisms that produce diabetes may explain the strong association between cystic fibrosis and pancreatic complications.

With obesity on the rise, bringing with it an increased risk of diabetes, cardiovascular disease, and other conditions, food labels may soon get a facelift.

The US Food and Drug Administration on Friday approved the first cholesterol-lowering treatment in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors.

Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) project, a 4-year Centers for Medicare and Medicaid Services-sponsored demonstration project, showed that a telemedicine intervention can improve glycemic, lipid, and blood pressure control.

Friday could be a big day for cardiologists. The FDA is due to rule July 24 on what could be the first available PCSK9 inhibitor, one of a new class of cholesterol-lowering agents meant to help patients who cannot get their LDL levels low enough with statins. New York City cardiologist David Vorchheimer, MD. talks about his hopes for the new drugs, and a few concerns

Both chronic pain conditions and obesity are major and increasing public health concerns, and the connections between the two have been firmly established in the medical literature. But as the prevalence of obesity worldwide continues to grow, a deeper understanding of this connection could potentially benefit both practitioners and patients.

When women present clinically with acne, hirsutism, and androgenetic alopecia, the likelihood is that the causative hormone is androgen. Collectively, these symptoms signal cutaneous hyperandrogenism.

New research into vitamin K deficiency among cystic fibrosis patients may help explain why exocrine pancreatic insufficiency increases the risk of pathological shortages.

A study evaluating glycemic response following insulin initiation for type 2 diabetes mellitus found that patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications at baseline and higher HbA1c levels.

A woman's lung cancer risk is not impacted by her reproductive history or prior hormone use.

Decreased vasoregulation in the brain leads to increased inflammation and loss of cognitive function in older adults with type 2 diabetes mellitus.

Treating patients with obesity or diabetes is no easy task for doctors despite the large number of options available to them and their patients. Taking into account the demographics of the patient population as well as the overall health of their individual patient.

Tocilizumab treated rheumatoid arthritis patients are at an increased risk for major adverse cardiovascular events, according to a study published in Arthritis & Rheumatology.

Study shows that diabetes duration (ie, how long they've had the disease) is linked with an increased risk of thromboembolism in patients with atrial fibrillation, but not with an increased risk of anticoagulation-related bleeding.

Anticoagulants may not be the ideal treatment for all patients with cirrhosis and portal hypertension but research is being done to find the best possible treatments for these patients.

Patients diagnosed with diabetes may be able to blame the food their ancestors ate for their condition as easily as they can blame their own eating habits, according to a recent study.

The reaction to an editorial claiming that exercise alone will not help patients lose weight is illustrative of the biases held by certain groups and underscores the need for greater education and awareness of the science of weight loss for patients and clinicians.

A recent study out of Finland found that men who ate chicken eggs on a regular basis had a lower risk of developing type 2 diabetes mellitus. Like a number of other recent studies this article stands in contrast to what was once the conventional wisdom: that eating foods high in cholesterol would increase your risk of heart disease and its risk factors.

The journal Paediatrics & Child Health recently published results from a research study completed by a team of researchers from across Canada that explored factors that influence the decision to engage in pediatric weight management programs.

The ‘cup of joe' that 54% of American adults consume every day, according to a survey, has a surprising effect on the risk of disease.

Not only have researchers uncovered a key factor that drives neuropathic pain, they have also identified a strategy to reverse it.

A review of research on the use of testosterone replacement therapy in men with a history of prostate cancer and in men with elevated prostate cancer risk found no evidence of statistically significant associations between such treatment and cancer progression.